Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

967 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Direct in vitro evidence of extracellular Ca2+-induced amino-terminal truncation of human parathyroid hormone (1-84) by human parathyroid cells.
Kawata T, Imanishi Y, Kobayashi K, Onoda N, Takemoto Y, Tahara H, Okuno S, Ishimura E, Miki T, Ishikawa T, Inaba M, Nishizawa Y. Kawata T, et al. Among authors: takemoto y. J Clin Endocrinol Metab. 2005 Oct;90(10):5774-8. doi: 10.1210/jc.2005-0243. Epub 2005 Jul 26. J Clin Endocrinol Metab. 2005. PMID: 16046589
Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels.
Kawata T, Imanishi Y, Kobayashi K, Onoda N, Okuno S, Takemoto Y, Komo T, Tahara H, Wada M, Nagano N, Ishimura E, Miki T, Ishikawa T, Inaba M, Nishizawa Y. Kawata T, et al. Among authors: takemoto y. J Bone Miner Metab. 2006;24(4):300-6. doi: 10.1007/s00774-006-0687-y. J Bone Miner Metab. 2006. PMID: 16816924
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.
J-DAVID Investigators; Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, Fujimori A, Fukui M, Hase H, Hashimoto T, Hirakata H, Honda H, Hosoya T, Ikari Y, Inaguma D, Inoue T, Isaka Y, Iseki K, Ishimura E, Itami N, Ito C, Kakuta T, Kawai T, Kawanishi H, Kobayashi S, Kumagai J, Maekawa K, Masakane I, Minakuchi J, Mitsuiki K, Mizuguchi T, Morimoto S, Murohara T, Nakatani T, Negi S, Nishi S, Nishikawa M, Ogawa T, Ohta K, Ohtake T, Okamura M, Okuno S, Shigematsu T, Sugimoto T, Suzuki M, Tahara H, Takemoto Y, Tanaka K, Tominaga Y, Tsubakihara Y, Tsujimoto Y, Tsuruya K, Ueda S, Watanabe Y, Yamagata K, Yamakawa T, Yano S, Yokoyama K, Yorioka N, Yoshiyama M, Nishizawa Y. J-DAVID Investigators, et al. Among authors: takemoto y. JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749. JAMA. 2018. PMID: 30535217 Free PMC article. Clinical Trial.
Cerebral microbleeds in predialysis patients with chronic kidney disease.
Shima H, Ishimura E, Naganuma T, Yamazaki T, Kobayashi I, Shidara K, Mori K, Takemoto Y, Shoji T, Inaba M, Okamura M, Nakatani T, Nishizawa Y. Shima H, et al. Among authors: takemoto y. Nephrol Dial Transplant. 2010 May;25(5):1554-9. doi: 10.1093/ndt/gfp694. Epub 2009 Dec 27. Nephrol Dial Transplant. 2010. PMID: 20037183
The Efficacy of Low-Density Lipoprotein Apheresis in a Patient with Drug-Resistant Minimal Change Nephrotic Syndrome: A Case Report and A Review of the Literature.
Nakatani S, Ishimura E, Okute Y, Nakatani A, Uedono H, Tsuda A, Naganuma T, Takemoto Y, Mori K, Emoto M, Inaba M. Nakatani S, et al. Among authors: takemoto y. Nephrology (Carlton). 2018 Jun;23(6):603-604. doi: 10.1111/nep.13120. Nephrology (Carlton). 2018. PMID: 29890046 Review. No abstract available.
967 results